세계의 홀터 심전도 시장 : 제품 유형별, 리드 유형별, 최종사용자별, 지역별 - 예측(-2030년)

The global Holter ECG market is projected to grow from USD 0.49 billion in 2025 to USD 0.76 billion by 2030, at a CAGR of 6.5% during this period. One of the primary factors driving market growth is the increasing prevalence of cardiovascular diseases. However, frequent product recalls may impact the growth of the Holter ECG market.

"The wired Holter ECG monitors segment held the largest share of the market in 2024."

The Holter ECG market is segmented based on product type into wired Holter ECG monitors, wireless Holter ECG monitors, and software. The wired Holter ECG monitors segment is further divided into conventional Holter ECG monitors, multi-channel Holter ECG monitors, and extended Holter ECG monitors. In contrast, the wireless Holter ECG monitors segment includes telemetry Holter ECG monitors, wearable Holter ECG monitors, and other wireless Holter ECG monitors.

The wired Holter ECG monitors segment is anticipated to dominate the market during the forecast period. This is due to the high accuracy and precision these devices offer in diagnosing heart activity. Additionally, the rising prevalence of cardiovascular diseases (CVD) and the increasing need to reduce treatment costs are driving growth in this segment.

"The hospitals & specialty clinics segment dominated the market in 2024."

The end-user market for Holter ECG devices is divided into hospitals & specialty clinics, ambulatory surgical centers, and other end users. During the forecast period, hospitals & specialty clinics are expected to hold the largest share of the global Holter ECG market. This dominance is largely due to the increasing prevalence of cardiovascular diseases (CVD) and a rise in the number of cardiac implant procedures.

"The market in the APAC region is expected to register the highest growth rate for Holter ECG monitors during the forecast period."

The Holter ECG market spans five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held a significant share of the Holter ECG market, primarily driven by the US and Canada. Conversely, the Asia Pacific region is projected to experience the highest growth rate during the forecast period. This growth can be attributed to the increasing market penetration opportunities in emerging countries within the Asia Pacific region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: Directors (25%), Managers (25%), and Others (50%)
• By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)

The key players in the Holter ECG market include GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Hill-Rom (Baxter) (US), Mindray Medical International Limited (China), SCHILLER AG (Switzerland), Bittium (Finland), FUKUDA DENSHI (Japan), BPL Medical Technologies (India), Qingdao Meditech Equipment Co., Ltd. (China), Midmark Corporation (US), CardioComm Solutions, Inc. (US), and VitalConnect (US). These companies are among the prominent players in the Holter ECG industry.

Research Coverage

This report studies the Holter ECG market based on product, lead type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help both established companies and new or smaller firms understand market trends, allowing them to capture a larger market share. Firms that purchase the report can use one or a combination of the strategies mentioned below to enhance their market presence.

This report provides insights on the following pointers:

• Analysis of key drivers (rising geriatric population, increasing prevalence of cardiovascular disease, technological advancements in wireless monitoring and wearable devices, and increasing investments, funds, and grants for research on cardiac monitoring), restraints (frequent product recalls), opportunities (untapped emerging markets), and challenges (stringent regulatory requirements delaying approval of cardiac devices and dearth of skilled professionals with expertise in handling cardiac monitoring devices) influencing the growth of the Holter ECG market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Holter ECG market
• Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the Holter ECG market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Holter ECG market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 STUDY LIMITATIONS
• 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
    • 2.1.1.2 Objectives of secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary interviews
    • 2.1.2.3 Objectives of primary research
• 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Growth forecast
  • 2.2.2 TOP-DOWN APPROACH
  • 2.2.3 PRIMARY RESEARCH VALIDATION
• 2.3 DATA TRIANGULATION
• 2.4 STUDY ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HOLTER ECG MARKET OVERVIEW
• 4.2 HOLTER ECG MARKET, BY PRODUCT, 2025 VS. 2030
• 4.3 EUROPE: HOLTER ECG MARKET, BY PRODUCT AND REGION (2024)
• 4.4 HOLTER ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.5 HOLTER ECG MARKET: REGIONAL MIX, 2023-2030 (USD MILLION)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising geriatric population and growing focus on patient monitoring
    • 5.2.1.2 Increasing prevalence of cardiovascular diseases
    • 5.2.1.3 Technological advancements in wireless monitoring and wearable devices
    • 5.2.1.4 Increasing funding investments for cardiac research monitoring
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Frequent product recalls
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High growth potential of emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stringent regulatory requirements for product commercialization
    • 5.2.4.2 Shortage of skilled professionals for operation of cardiac monitoring devices
• 5.3 REGULATORY SCENARIO
  • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
  • 5.3.2 REGULATORY FRAMEWORK
    • 5.3.2.1 North America
      • 5.3.2.1.1 US
      • 5.3.2.1.2 Canada
    • 5.3.2.2 Europe
    • 5.3.2.3 Asia Pacific
      • 5.3.2.3.1 China
      • 5.3.2.3.2 Japan
      • 5.3.2.3.3 India
    • 5.3.2.4 Latin America
      • 5.3.2.4.1 Brazil
      • 5.3.2.4.2 Mexico
    • 5.3.2.5 Middle East
    • 5.3.2.6 Africa
• 5.4 VALUE CHAIN ANALYSIS
  • 5.4.1 RESEARCH & DEVELOPMENT
  • 5.4.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
  • 5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.5 SUPPLY CHAIN ANALYSIS
  • 5.5.1 PROMINENT COMPANIES
  • 5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
  • 5.5.3 DISTRIBUTORS
  • 5.5.4 END USERS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 KEY BUYING CRITERIA
• 5.9 CASE STUDY ANALYSIS
  • 5.9.1 CASE STUDY 1
  • 5.9.2 CASE STUDY 2
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA HS CODE 901811
  • 5.10.2 EXPORT DATA HS CODE 901811
• 5.11 PATENT ANALYSIS
  • 5.11.1 LIST OF PRIMARY PATENTS
• 5.12 PRICING ANALYSIS
  • 5.12.1 AVERAGE SELLING PRICE FOR WIRED HOLTER ECG MONITORS
    • 5.12.1.1 Average selling price trend for Wired Holter ECG monitors
  • 5.12.2 AVERAGE SELLING PRICE, BY REGION
    • 5.12.2.1 Average selling price trend of wired Holter ECG monitors, by region
• 5.13 TECHNOLOGY ANALYSIS
  • 5.13.1 KEY TECHNOLOGIES
    • 5.13.1.1 Digital ECG recording & signal processing
    • 5.13.1.2 Cloud-based data storage & remote monitoring
    • 5.13.1.3 Wireless & Bluetooth connectivity
    • 5.13.1.4 Multi-channel ECG monitoring
  • 5.13.2 COMPLEMENTARY TECHNOLOGIES
    • 5.13.2.1 Telemetry & real-time ECG Transmission
    • 5.13.2.2 Patch-based & wearable ECG devices
    • 5.13.2.3 Mobile & wearable health apps
  • 5.13.3 ADJACENT TECHNOLOGIES
    • 5.13.3.1 Implantable Loop Recorders (ILRS)
    • 5.13.3.2 AI-driven predictive cardiology solutions
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.15.1 REVENUE SHIFT & REVENUE POCKETS FOR HOLTER ECG MANUFACTURERS
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 UNMET NEEDS
• 5.18 IMPACT OF AI/GEN AI ON HOLTER ECG MARKET
• 5.19 IMPACT OF 2025 US TARIFF-HOLTER ECG MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
  • 5.19.4 PRICE IMPACT ON COUNTRY/REGION
    • 5.19.4.1 US
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END-USE INDUSTRIES

6 HOLTER ECG MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 WIRED HOLTER ECG MONITORS
  • 6.2.1 CONVENTIONAL HOLTER ECG MONITORS
    • 6.2.1.1 Continued reliability and simplicity to boost demand
  • 6.2.2 MULTI-CHANNEL HOLTER ECG MONITORS
    • 6.2.2.1 Enhanced diagnostic capabilities to support market penetration
  • 6.2.3 EXTENDED HOLTER ECG MONITORS
    • 6.2.3.1 Growing preference for long-term monitoring to enhance diagnostic accuracy
• 6.3 WIRELESS HOLTER ECG MONITORS
  • 6.3.1 TELEMETRY HOLTER ECG MONITORS
    • 6.3.1.1 Real-time data transmission and mobility to fuel market
  • 6.3.2 WEARABLE HOLTER ECG MONITORS
    • 6.3.2.1 Enhanced patient compliance and real-time data to boost demand
  • 6.3.3 OTHER WIRELESS HOLTER ECG MONITORS
• 6.4 SOFTWARE
  • 6.4.1 INTEGRATION OF PATIENT DATA WITH RAPID INSIGHTS TO SUPPORT MARKET GROWTH

7 HOLTER ECG MARKET, BY LEAD TYPE

• 7.1 INTRODUCTION
• 7.2 PATCH TYPE 1-LEAD HOLTER MONITORS
  • 7.2.1 ABILITY TO OFFER RAPID RESULTS TO DRIVE MARKET
• 7.3 3-LEAD HOLTER MONITORS
  • 7.3.1 ABILITY TO PERFORM MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY TO BOOST DEMAND
• 7.4 6-LEAD HOLTER MONITORS
  • 7.4.1 WIDE APPLICATIONS ACROSS REMOTE PATIENT MONITORING TO BOOST DEMAND
• 7.5 12-LEAD HOLTER MONITORS
  • 7.5.1 UTILIZATION ACROSS HOSPITALS & CLINIC SETTINGS TO PROPEL MARKET
• 7.6 OTHER LEAD TYPES

8 HOLTER ECG MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS AND SPECIALTY CLINICS
  • 8.2.1 INCREASING ESTABLISHMENT OF CARDIAC CENTERS TO DRIVE MARKET
• 8.3 AMBULATORY SURGERY CENTERS
  • 8.3.1 LOW-COST PROCEDURES WITH HIGH CONVENIENCE TO BOOST DEMAND
• 8.4 OTHER END USERS

9 HOLTER ECG MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 High healthcare expenditure to drive market
  • 9.2.3 CANADA
    • 9.2.3.1 Rising prevalence of lifestyle diseases to boost demand
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Favorable government policies for advanced cardiac treatments to fuel uptake
  • 9.3.3 UK
    • 9.3.3.1 Increasing demand for home-based cardiac monitoring devices to support market growth
  • 9.3.4 FRANCE
    • 9.3.4.1 Rising incidence of CVD and stroke to propel market
  • 9.3.5 ITALY
    • 9.3.5.1 Rising cases of obesity and CVD to boost demand
  • 9.3.6 SPAIN
    • 9.3.6.1 Growing focus on cardiac monitoring to fuel market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Increasing public access to modern healthcare to aid market
  • 9.4.3 JAPAN
    • 9.4.3.1 Favorable regulatory framework for product commercialization to drive market
  • 9.4.4 INDIA
    • 9.4.4.1 Favorable healthcare investments to support market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Supportive healthcare initiatives for advanced care to fuel market
  • 9.4.6 THAILAND
    • 9.4.6.1 Rising demand for advanced healthcare diagnostics to fuel market
  • 9.4.7 SINGAPORE
    • 9.4.7.1 Establishment of advanced healthcare facilities to fuel market
  • 9.4.8 INDONESIA
    • 9.4.8.1 Collaborations among medical device companies to boost market
  • 9.4.9 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increasing prevalence of CVD to drive market
  • 9.5.3 MEXICO
    • 9.5.3.1 Expansion of leading market players for innovative products to support market growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Increasing rates for medical tourism to drive market
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HOLTER ECG MARKET
• 10.3 REVENUE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.4.1 RANKING OF KEY MARKET PLAYERS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Product footprint
    • 10.5.5.4 Lead type footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.6.5.1 Detailed list of key startup/SME players
    • 10.6.5.2 Competitive benchmarking of key emerging players/startups
• 10.7 VALUATION & FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS
  • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 GE HEALTHCARE TECHNOLOGIES INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 KONINKLIJKE PHILIPS N.V.
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches & approvals
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Expansions
      • 11.1.2.3.4 Other developments
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 NIHON KOHDEN CORPORATION
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 MnM view
      • 11.1.3.3.1 Key strengths
      • 11.1.3.3.2 Strategic choices
      • 11.1.3.3.3 Weaknesses & competitive threats
  • 11.1.4 OSI SYSTEMS, INC.
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 HILLROM (BAXTER INTERNATIONAL INC.)
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Key strengths
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses & competitive threats
  • 11.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Deals
  • 11.1.7 SCHILLER AG
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product launches
  • 11.1.8 BITTIUM
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
  • 11.1.9 FUKUDA DENSHI CO., LTD.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 BPL MEDICAL TECHNOLOGIES PVT. LTD.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Expansions
  • 11.1.11 CARDIOLINE
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches & approvals
• 11.2 OTHER PLAYERS
  • 11.2.1 QINGDAO MEDITECH EQUIPMENT CO., LTD (MEDITECH GROUP)
  • 11.2.2 EDAN INSTRUMENTS, INC.
  • 11.2.3 MIDMARK CORPORATION
  • 11.2.4 CARDIOCOMM SOLUTIONS, INC.
  • 11.2.5 VITALCONNECT
  • 11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD.
  • 11.2.7 NASIFF ASSOCIATES INC.
  • 11.2.8 VECTRACOR
  • 11.2.9 SCOTTCARE
  • 11.2.10 BIOMEDICAL INSTRUMENTS CO., LTD.
  • 11.2.11 EB NEURO S.P.A.
  • 11.2.12 VIATOM TECHNOLOGY CO., LTD.
  • 11.2.13 BIOTRICITY
  • 11.2.14 NASAN MEDICAL ELECTRONICS PVT. LTD.
  • 11.2.15 LIFESIGNALS

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS